FDA.reportPublic FDA data

Application 075845

Type
ANDA
Sponsor
SANDOZ

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001OXAPROZINOXAPROZINTABLET;ORAL600MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0185-0141OxaprozinOxaprozinEon Labs, Inc.ANDACurrent
0185-0141OxaprozinOxaprozinEon Labs, Inc.ANDACurrent
0185-0141OxaprozinOxaprozinEon Labs, Inc.ANDACurrent
0185-0141OxaprozinOxaprozinEon Labs, Inc.ANDACurrent
60760-203OxaprozinOxaprozinSt. Mary's Medical Park PharmacyANDACurrent
61919-673OXAPROZINOXAPROZINDIRECT RXANDACurrent
63629-8724OxaprozinOxaprozinBryant Ranch PrepackANDACurrent
63629-8724OxaprozinOxaprozinBryant Ranch PrepackANDACurrent
66336-722OxaprozinOxaprozinDispensing Solutions, Inc.ANDACurrent
68151-0523OxaprozinOxaprozinCarilion Materials ManagementANDACurrent
71335-0902OxaprozinOxaprozinBryant Ranch PrepackANDACurrent
71335-0902OxaprozinOxaprozinBryant Ranch PrepackANDACurrent
71335-0902OxaprozinOxaprozinBryant Ranch PrepackANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
8807ORIG2001-01-31